Swiss National Bank’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
108,900
+1,400
| +1% | +$19.6K | ﹤0.01% | 1942 |
|
|
2025
Q1 | $1.45M | Sell |
107,500
-5,100
| -5% | -$68.7K | ﹤0.01% | 1950 |
|
|
2024
Q4 | $2.16M | Buy |
112,600
+4,500
| +4% | +$86.3K | ﹤0.01% | 1810 |
|
|
2024
Q3 | $2.46M | Buy |
108,100
+15,500
| +17% | +$353K | ﹤0.01% | 1742 |
|
|
2024
Q2 | $1.2M | Buy |
92,600
+9,700
| +12% | +$126K | ﹤0.01% | 2075 |
|
|
2024
Q1 | $1.45M | Buy |
82,900
+15,700
| +23% | +$275K | ﹤0.01% | 2019 |
|
|
2023
Q4 | $1.46M | Buy |
67,200
+800
| +1% | +$17.4K | ﹤0.01% | 2026 |
|
|
2023
Q3 | $1.02M | Buy |
66,400
+5,700
| +9% | +$87.4K | ﹤0.01% | 2237 |
|
|
2023
Q2 | $1.44M | Sell |
60,700
-4,400
| -7% | -$105K | ﹤0.01% | 2101 |
|
|
2023
Q1 | $1.66M | Sell |
65,100
-7,100
| -10% | -$181K | ﹤0.01% | 1954 |
|
|
2022
Q4 | $2.11M | Buy |
72,200
+4,800
| +7% | +$140K | ﹤0.01% | 1864 |
|
|
2022
Q3 | $1.38M | Buy |
67,400
+30,700
| +84% | +$629K | ﹤0.01% | 2128 |
|
|
2022
Q2 | $425K | Buy |
+36,700
| New | +$425K | ﹤0.01% | 2652 |
|